Bedel Financial Consulting »

ResMed shares owned by Bedel Financial Consulting

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Bedel Financial Consulting from 13F filings

Historical chart of Bedel Financial Consulting investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Bedel Financial Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Bedel Financial Consulting

Quarter filed Position value Share count Share price at filing
2023-09-30 $311k 2.1k 147.87

More positions owned by Bedel Financial Consulting

Eli Lilly & Co. (LLY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Apple (AAPL)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Grwth Etf (EFG)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Innovator Etfs Tr Us Eqt Pwr Buf (PAPR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Global X Fds Rate Preferred (PFFV)
JPMorgan Chase & Co. (JPM)
Ishares Tr MRGSTR MD CP GRW (IMCG)

View all positions for Bedel Financial Consulting

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Invesco
Northern Trust
Legal & General Group
Select Equity
Charles Schwab Investment Management
Goldman Sachs Group
Ubs Global Asset Management Americas
Greenvale Capital
Dimensional Fund Advisors
Jpmorgan Chase & Co

View all funds holding ResMed